மேட் ஹெவிட் கிரேக் மண்டபம் மூலதனம் குழு ஆய்வாளர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மேட் ஹெவிட் கிரேக் மண்டபம் மூலதனம் குழு ஆய்வாளர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மேட் ஹெவிட் கிரேக் மண்டபம் மூலதனம் குழு ஆய்வாளர் Today - Breaking & Trending Today

Repligen Corp (RGEN) Q1 2021 Earnings Call Transcript


Repligen Corp (RGEN) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Repligen Corp (NASDAQ: RGEN)
Operator
Good day, ladies and gentlemen, and welcome to Repligen Corporation s First Quarter 2021 Earnings Conference Call. My name is Ailey and I will be your coordinator.
[Operator Instructions]
I would now like to turn the call over to your host for today s call, Sondra Newman, Head of Investor Relations for Repligen.SPONSORED:
10 stocks we like better than Repligen
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , Matt Hewitt , Dan Arias Stifel , Dan Arias , Julia Kan , Paul Knight Keybanc , Ram Selvaraju , Brandon Couillard Jefferies , Jon Snodgres , Paul Knight , Brandon Couillard , Sondra Newman , Jacob Johnson , Puneet Souda , Sondras Newman , Jonk Snodgres , Tony Hunt , Matt Hewitt Craig Hallum Capital Group Analyst , Stephens Inc , Craig Hallum Capital Group , Repligen Corp , Repligen Corporation First Quarter , Motley Fool Repligen Corp , Mason Carrico Stephens Inc , Call Transcript , Motley Fool Logo ,

Vocera Communications (VCRA) Q1 2021 Earnings Call Transcript


Vocera Communications (VCRA) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Vocera Communications (NYSE: VCRA)
Please proceed.
Director of Investor Relations
Thank you. Hello, everyone. Welcome to Vocera s conference call to discuss our first quarter fiscal 2021 earnings as well as the acquisition we announced today. This is Sue Dooley of Vocera s investor relations and joining me today are our CEO, Brent Lang; and Justin Spencer, our CFO.
And I would like to welcome Steve Anheier to our call. Steve will become our CFO in June. Earlier today, we distributed two press releases detailing our two announcements. Both releases are posted on our website and are also available from normal news sources. ....

United States , New Zealand , United Kingdom , San Diego , Matt Hewitt , Steve Anheier , Piper Sandler , Ryan Daniels William Blair , Sean Wieland Piper Sandler , Scott Schoenhaus , Ryan Daniels , Justin Spencer , Brent Lang , Sean Wieland , Stephanie Davis , William Blair , Vocera Smartbadge , Barnabas Men Ministry Of Health , Business Intelligence Group , University Health Network , Matt Hewitt Craig Hallum Capital Group Analyst , Motley Fool Vocera Communications , Patientsafe Solutions , Ministry Of Health , Rwjbarnabas Health , Vocera Communications ,

Ligand Pharmaceuticals Inc (LGND) Q4 2020 Earnings Call Transcript


Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Ligand Pharmaceuticals Q4 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Patrick O Brien. Thank you. Please go ahead.
Patrick O Brien
Investor Relations
Thank you, Brandy. And welcome to Ligand s fourth quarter of 2020 financial results and business update conference call. All of our speakers for today s call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO. We will use non-GAAP financial measures and some of our statements will be forward-looking. Additional information concerning risk factors and other matters concerning Ligand can be found in our Ligand s earning press release and our periodic filings with the SEC. Ligand undertakes no obligation to revise or update any statements to reflect events or circumstances after the date of this confe ....

United States , Matt Hewitt , Patrick Obrien , Matt Foehr , Matthew Foehr , Matt Korenberg , Balaji Prasad Barclays , John Higgins , Joe Pantginis , Balaji Prasad , Scott Henry , Dana Flanders , Matt Hewitt Craig Hallum Capital Group Analyst , Ligand Pharmaceuticals , Ligand Pharmaceuticals Inc , Jazz Pharmaceuticals , Cystic Fibrosis Foundation , Dana Flanders Guggenheim Securities , Stanford University , Joseph Pantginis Hc Wainwright Co , Vice President , Chief Financial , Analyst Day , Chief Operating , Antibody Discovery Tech , Biological Intelligence ,